SCHEMBL9702558

SCHEMBL9702558

CCCCSc1c(OCC)cc(OCC)cc1-c1ccc(C#N)c(=O)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.41
AR P10275 3/20 0.40
GLA P06280 2/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
IDH1 O75874 2/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
MAPK1 P28482 1/20 0.33
PDE5A O76074 1/20 0.32
KMT2A Q03164 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
MDM2 Q00987 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9525834 0.80 KDM4E (0.44) ALDH1A1KDM4EARGLAGAA
SCHEMBL9525926 0.78 CYP2C9 (0.31) ALDH1A1KDM4EMAPTMAPK1
SCHEMBL7371784 0.73 KDM4E (0.60) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL9530230 0.73 MDM2 (0.41) ALDH1A1KDM4EHPGDLMNAPOLB
SCHEMBL7646365 0.72 PDE5A (0.50) ALDH1A1KDM4EARGLAGAA
SCHEMBL9525541 0.71 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDARGLA
SCHEMBL9526882 0.70 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL9702581 0.70 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL7646385 0.69 PDE5A (0.44) ALDH1A1KDM4EHPGDLMNAAR
SCHEMBL9702565 0.69 KDM4E (0.55) ALDH1A1KDM4EHPGDLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992006085-A1 PHENYLPYRIDINOL DERIVATIVES AS MEDICAMENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1992-04-16 WO disclosed